Microfluidic cellular models, commonly referred to as "organs-on-chips," continue to advance the field of bioengineering via the development of accurate and higher throughput models, captivating the essence of living human organs. This class of models can mimic key in vivo features, including shear stresses and cellular architectures, in ways that cannot be realized by traditional two-dimensional in vitro models. Despite such progress, current organ-on-a-chip models are often overly complex, require highly specialized setups and equipment, and lack the ability to easily ascertain temporal and spatial differences in the transport kinetics of compounds translocating across cellular barriers. To address this challenge, we report the development of a threedimensional human blood brain barrier (BBB) microfluidic model (μHuB) using human cerebral microvascular endothelial cells (hCMEC/D3) and primary human astrocytes within a commercially available microfluidic platform. Within μHuB, hCMEC/D3 monolayers withstood physiologically relevant shear stresses (2.73 dyn/cm 2 ) over a period of 24 hr and formed a complete inner lumen, resembling in vivo blood capillaries. Monolayers within μHuB expressed phenotypical tight junction markers (Claudin-5 and ZO-1), which increased expression after the presence of hemodynamic-like shear stress. Negligible cell injury was observed when the monolayers were cultured statically, conditioned to shear stress, and subjected to nonfluorescent dextran (70 kDa) transport studies. μHuB experienced size-selective permeability of 10 and 70 kDa dextrans similar to other BBB models. However, with the ability to probe temporal and spatial evolution of solute distribution, μHuBs possess the ability to capture the true variability in permeability across a cellular monolayer over time and allow for evaluation of the full breadth of permeabilities that would otherwise be lost using traditional end-point sampling techniques.
| INTRODUCTION
The blood-brain barrier (BBB) is the prominent barrier at the interface of the blood stream and the central nervous system (CNS) and is primarily responsible for maintaining brain homeostasis and protecting the CNS from harmful foreign entities. 1 As the brain's first line of defense against solutes and particulates in the blood, the brain microvascular endothelial cells form a tight barrier that limits the transport of nutrients and other molecules into and out of the CNS space. Combined with pericytes and astrocytes, these cells collectively form a neurovascular unit, contributing to the overall BBB phenotype. The brain endothelium is characterized by expression of tight junction complexes lack of fenestrations, and low pinocytic activity. 2, 3 Although these characteristics are imperative for normal brain function, the BBB limits the penetration of therapeutics into the brain. 4 As a result, there is a clear need for the development of adequate models to further investigate the mechanisms of transport across the BBB in order to design better brain delivery strategies.
Assessing transport of nanoparticles, proteins, and other therapeutics across the BBB can be challenging; nonetheless, researchers have designed various in vivo models to investigate this transport in both heathy and diseased BBB. [5] [6] [7] [8] Animal models inherently include all contributing factors that dictate the transport across the BBB.
However, translating findings from rodent models to humans remains a challenge. 9, 10 Further, the complexity of the in vivo environment also poses a challenge for interpreting the results. For example, transport of nanoparticles into the brain in vivo is a combined outcome of immune clearance and permeation across the BBB, thus making it difficult to deconvolute the contributions of each factor from the measured experimental outcome. Common techniques to investigate BBB transport of therapeutics in vivo include single carotid injections, internal carotid artery perfusion, and intravenous injections. 11, 12 Using intravenous injections can be disadvantageous for investigating BBB transport due to the potential rapid metabolism of the therapeutic, resulting in metabolism-induced artifacts and greater likelihood of clearance before reaching the brain microcirculation. Alternatively, single carotid injections and internal carotid artery perfusions can reduce the likelihood of clearance while also limiting metabolic events within the brain microcirculation. Unfortunately, these techniques are labor-intensive, requiring significant training and expertise to properly implement. 13 As a result, there continue to be strong interests in
developing simple yet physiologically relevant in vitro models of the human BBB that are also highly tunable and customizable to be used as tools to further investigate brain-related phenomena.
To date, the primary in vitro tool of choice for researchers studying human BBB permeability is the static transwell migration assay, also referred to as the Boyden chamber assay. These assays offer the flexibility to conduct both monolayer 14 and coculture experiments, [15] [16] [17] can noninvasively estimate barrier permeability using transendothelial electrical resistance (TEER) measurements, and are convenient for acquiring permeability information across a monolayer, including disease models. [18] [19] [20] However, transwell inserts can be subject to increased, artificial paracellular diffusion at the monolayer perimeter by a phenomenon known as "edge effects," especially for highly hydrophilic compounds. 21 This erroneous effect results from incomplete coverage of the porous inserts at the monolayer perimeter due to the inability of the endothelial cells to form tight junctions along the inner wall of the apical chamber. 22 Typically, analyte concentrations are sampled from the apical or basolateral chamber over time without the ability to actively monitor transport.
Additionally, depending on the cell culturing conditions and experimental setup, TEER values can vary significantly. 23 To confound these reported values further, reports often misrepresent the TEER value by describing it in terms of total resistance or area-dependent resistance.
Hemodynamic shear stress experienced by endothelial cells is an important mechanotransduction regulator not present in static transwell migration assays. Depending on the blood vessel geometry and condition, endothelial cells can experience a range of shear stresses.
In vitro studies report shear stresses between <1 and 85 dyn/cm 2 induce a variety of biological responses. 24 For instance, shear stress acts as a pleiotropic modulator of the endothelial cell physiology, regulating genes involved in cell division, differentiation, migration, extracellular matrix protein secretion, cell-cell adhesion, and apoptosis. 25 As a result, shear stress contributes to an overall polarized brain endothelium, influencing such properties as asymmetric expression of localized enzymes and carrier-mediated transport systems, production of vasoactive substances and cell adhesion molecules, cell survival, and energy metabolism. [26] [27] [28] 2 | RESULTS
| Culture of hCMEC/D3 cells in μHuB device
The scaffold for μHuB is a commercial microfluidic device (SynVivo with other transwell models with a pore size of 3 μm, which are commonly used to study transport across static in vitro models. 52 Initially, devices were coated with a variety of basement membranes, including rat tail collagen Type 1, human fibronectin, and laminin, which have been used to promote cell adhesion in the literature. 40, 53, 54 Optimal cell adhesion was observed with a thin coating of human fibronectin and was used for all studies reported. Consistent cell attachment to the upper portion of the PDMS channel proved challenging using standard injection techniques. Therefore, we adopted a two-step With the added ability to observe transport in real time within the μHuB, localized permeabilities can be calculated for precise temporal regions of interest. Using the representative data in Figure 6d , the intensity profile could exhibit three regions with different slopes: a relatively rapid increase at early time points, a more gradual increase at later time points, and a final plateau region. By calculating the inflection points with higher order fits, the described transitions between these regions occur at approximately t = 60 min and t = 90 min for the inflection and plateau, respectively. Fitting different slopes on either side of the inflection point results in a more precise fit of the data compared to using a single slope for the profile (Figure 6f ).
To assess the vitality of the monolayers in the μHuB after a transport experiment, cell viability of the monolayers in the μHuB was investigated on shear stress-conditioned cells after 6 hr of constant flow with cell culture medium and after an additional 3 hr of constant flow with a nonfluorescent 70 kDa dextran solution (312.5 nM) to ensure no fluorescence interference with the viability assay resulted.
As demonstrated in Figure 5c , monolayers continued to exhibit high cell viability and low cell toxicity, indicating the largest molecular weight dextran solution had no significant impact on the viability of the μHuB model over the observed time periods and at this concentration. 
| Expansion of the μHuB model with astrocytes

| Discussion
We have presented the design and characterization of a realistic yet simple in vitro model of the human BBB: μHuB. Importantly, the μHuB recapitulates several of the most critical aspects of the in vivo BBB, specifically the incorporation of appropriate brain endothelial cells 59 into a vessel-like architecture that exposes the cells to shear. 66 Moreover, by combining a commercially available, immortalized cell line with a straightforward, commercially available microfluidic chip, we have developed a highly accessible model that can be readily adopted and utilized as an experimental tool and analysis method for dynamically visualizing particulates of interest in future studies. An essential, functional participant of the neurovascular unit is the basement membrane. Basement membrane in the brain is primarily composed of laminins and collagen IV. 67 We found, however, that hCMEC/D3 cellular morphology and adherence to the internal glass and PDMS surfaces were optimal when coated with human fibronectin. This may be partially attributed to the structural support provided by the chip itself, as collagen IV has been implicated to have a primarily structural, scaffold-like function. 68 having Stokes' radii >10 Å. [74] [75] [76] As in vitro models do not fully recapitulate all of the necessary components for such a "tight" BBB, researchers often use dextrans with varying Stokes' radii to determine the relative "leakiness" due to passive diffusion around the endothelial cells. As expected, a size-dependent trend was observed in the permeability (P e ), where molecules with a larger Stokes' radii crossed the barrier at a reduced rate ( Figure 6 ).
Overall, transport of the tracers reported were comparable in magnitude to those measured in prior experimental work using neonatal rat brain endothelial cells on a similar scaffold design (15 × 10
cm/s for a 10 kDa dextran reported here versus 40 × 10 −6 cm/s for a larger 40 kDa dextran reported by Deosarkar and coworkers). 40 Our permeability data also agree with mathematical modeling to calculate permeability values for macromolecules with similar Stokes' radii across an endothelial barrier. 65 The permeabilities reported in our study were calculated based on our current understanding of small macromolecule translocation across the BBB, namely that the transport of dextran tracers through the BBB should remain constant with time. The transport data acquired using the μHuB can also be used to investigate potential temporal differences in permeability. As seen in Figure 6f , different temporal regions of a single experiment can have apparent permeabilities that differ over twofold but are still comparable to previously reported literature. To our knowledge, these differences are unlikely to be captured using other tools. With the dynamic visualization capability of the μHuB, heterogeneities originating from spatial biological variability can also be assessed in a single experiment by analyzing the local permeability at different azimuthal locations along the semipermeable barrier. To our knowledge, investigations into this type of variability have not been reported to date. As a result, the μHuB can be a powerful tool for developing a deeper mechanistic understanding of any type of particulate transport through the BBB both in time and space.
As the blood-brain barrier consists of various cell types in addition to brain endothelial cells, including astrocytes, pericytes, and glial cells, a coculture of primary human astrocytes and hCMEC/D3 was successfully cultured using a similar protocol for the hCMEC/D3 only models to achieve complete lining of the central compartment with 
| Conclusions
We have reported the development of μHuB, an easy-to-use human For coculture experiments, primary human astrocytes (Catalog #1800) were obtained from ScienCell and maintained astrocyte medium (Catalog #1801) also obtained from ScienCell. Cells were cultured on poly-L-lysine coated tissue culture flasks (2 μg/cm 2 ), which were allowed to coat in the incubator overnight prior to use. Cells were incubated at 37 C, 95% humidity and 5% CO 2 until confluent.
3.3 | Culture of hCMEC/D3 and primary astrocytes in μHuB
To facilitate endothelial cell attachment, human fibronectin (300 μg/ mL) was injected in the outer compartment and allowed to incubate for 1 hr at 37 C and 5% CO 2 . The entire device was perfused with complete cell culture media. To devoid the device from any residual entrapped air, the device was primed using inert N 2 gas at 6 PSI for 30 min. Devices were placed inside cell culture incubator prior to use.
For coculture experiments, the device was first perfused with a thincoating of Matrigel (1:5) in the central compartment for 1 hr at 37 C and 5% CO 2 prior to coating the outer channels with human fibronectin (300 μg/mL) as described previously.
hCMEC/D3 grown to 70 to 80% confluency were trypsinized and resuspended in cell culture media with increased serum concentration (10%). Cell suspension at~5 × 10 7 cells/mL was injected into the outer compartment at 6 μL/mL using a Harvard Apparatus Pump 3.6 | Tight junction protein characterization in μHuB (ZO-1, Claudin-5)
After flow-conditioning, μHuB was perfused with DPBS to replace the cell culture media. 4% PFA was injected into all device compartments and allowed to remain at room temperature for 15 min. The device was again perfused with DPBS to remove any residual PFA. Fixed cells were then permeabilized using 0.2% Triton X-100 in DPBS for 10 min.
The device was again perfused with DPBS to move any residual Triton X-100. The device was blocked with 5% donkey serum and 5% goat serum for 30 min at room temperature. ZO-1 (1:100) and Claudin-5
(1:200) primary antibodies were diluted in antibody diluting buffer (0.1% Tween-20 and 0.1% BSA) at 4 C overnight. Corresponding fluorescently labeled secondary antibodies Anti-Goat and AntiDonkey (1:1000) was allowed to incubate for 1 hr at room temperature prior to perfusing with DPBS and was immediately imaged.
| Acquisition of transport information in μHuB
Following flow-conditioning, 312.5 nM of FITC-Dextran (10 and 70 kDa) was injected into the apical channel at 5 μL/min over 2 hr.
Device was maintained humidified and at 37 C and 5% CO 2 using a Zeiss environmental enclosure. Images were acquired using a 5X objective in 1 min intervals for the duration of the experiment.
| Quantification of FITC-dextran permeation using fluorescent microscopy
Acquired fluorescent image stacks from transport experiments were imported into MATLAB and analyzed using a custom code. Briefly, the average pixel intensity and standard deviation within the apical channel and the basolateral chambers were calculated for each frame.
Intensity in the basolateral chamber was normalized to the equilibrium intensity of the apical channel, resulting in a normalized intensity profile ( Figure 6c ). Frames collected prior to the apical chamber reaching an equilibrium intensity were excluded from the analysis. Permeability was calculated from the normalized intensity profiles using:
where V/S is the ratio of apical volume to surface area. The linear portion of the resulting intensity over time curve was fit to a line using the MATLAB fit function and weighting with the standard deviations of the intensity. The slope of this line was then used to calculate the permeability as shown in Equation 1 and as described in previous work. 40, 81 Stationary and inflection points were identified using quadratic and cubic fits, respectively, with identical weighting. The permeability of the analyte was assessed by using frames acquired before the intensity profile plateaued. For example, Figure 6d shows a normalized intensity profile for 70 kDa dextran. As before, frames collected prior to the apical chamber reaching its equilibrium value are not included. The profile plateaus between t = 50 min and t = 100 min. Based on the fitting inflection points, this curve changes slopes at t = 60 min. Only frames before t = 60 min were used for the permeability calculations. Permeability of the acellular scaffold (P scaffold )
was subtracted from the overall permeability observed (P total ) to calculate the true permeability of the endothelial cell barrier (P e ) for a given tracer (Equation 2). 82 1 P e ¼ 1 P total − 1 P scaffold ð2Þ
| Statistical analysis
Experiments were run in triplicate, and permeability error bars represent a 95% confidence interval based on the linear fitting. 
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